NasdaqGS - Nasdaq Real Time Price USD
Alkermes plc (ALKS)
50.45 +2.38 (+4.95%)
At close: 4:00:01 PM EDT
50.45 0.00 (0.00%)
After hours: 5:44:23 PM EDT
Trade ALKS on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreChart Range Bar
Loading chart for ALKS
- Previous Close
48.07 - Open
48.91 - Bid 43.12 x 100
- Ask 57.87 x 100
- Day's Range
48.88 - 51.73 - 52 Week Range
25.17 - 51.73 - Volume
3,725,867 - Avg. Volume
2,362,809 - Market Cap (intraday)
8.409B - Beta (5Y Monthly) 0.33
- PE Ratio (TTM)
56.06 - EPS (TTM)
0.90 - Earnings Date (est.) Jul 28, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
47.69
Recent News
View More
Performance Overview
Trailing total returns as of 6/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
ALKS
80.31%
S&P 500 (^GSPC)
7.49%
1-Year Return
ALKS
71.89%
S&P 500 (^GSPC)
20.78%
3-Year Return
ALKS
51.32%
S&P 500 (^GSPC)
69.22%
5-Year Return
ALKS
105.75%
S&P 500 (^GSPC)
72.47%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
As of 6/23/2026
Market Cap
8.01B
Enterprise Value
9.08B
Trailing P/E
53.40
Forward P/E
126.58
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.17
Price/Book (mrq)
4.57
Enterprise Value/Revenue
5.81
Enterprise Value/EBITDA
32.85
Financial Highlights
Profitability and Income Statement
Profit Margin
9.77%
Return on Assets (ttm)
4.72%
Return on Equity (ttm)
9.36%
Revenue (ttm)
1.56B
Net Income Avi to Common (ttm)
152.72M
Diluted EPS (ttm)
0.90
Balance Sheet and Cash Flow
Total Cash (mrq)
511.86M
Total Debt/Equity (mrq)
90.30%
Levered Free Cash Flow (ttm)
140.55M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Mkt Cap undefined -
Industry -
549.90
+1.02%
Mkt Cap 23.341B
Industry Drug Manufacturers—Specialty & Generic
17.00
+3.85%
Mkt Cap 1.89B
Industry Drug Manufacturers—Specialty & Generic
166.06
+2.86%
Mkt Cap 16.697B
Industry Drug Manufacturers—Specialty & Generic
23.96
+1.91%
Mkt Cap 942.776M
Industry Drug Manufacturers—Specialty & Generic
35.58
+2.77%
Mkt Cap 1.154B
Industry Drug Manufacturers—Specialty & Generic
3.9100
+1.30%
Mkt Cap 643.638M
Industry Drug Manufacturers—Specialty & Generic
59.13
-0.61%
Mkt Cap 4.549B
Industry Drug Manufacturers—Specialty & Generic
23.50
0.00%
Mkt Cap 151.861M
Industry Drug Manufacturers—Specialty & Generic
10.00
+7.41%
Mkt Cap 2.542B
Industry Drug Manufacturers—Specialty & Generic
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected. Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.